Copyright: ©Author(s) 2026.
World J Clin Oncol. Mar 24, 2026; 17(3): 116534
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.116534
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.116534
Table 2 Anti-gastric cancer effects and corresponding mechanisms of traditional Chinese medicine formulae
| TCM formulae | Compounds/constituents | Functions | Clinical stage | Experimental model | Effect | Specific mechanisms (pathways/targets) | Ref. |
| Sijunzi decoction | Radix Glycyrrhiizae (Gancao), Radix Ginseng (Renshen), Poria cocos Schw. (Fuling) and Rhizoma Atractylodes (Baizhu) | Nourishing spleen and enrich qi | GC tumor recurrence and treatment resistance | In vitro (MKN74 cellsand MKN45 cells) | Anti-tumor | Inhibit the nuclear accumulation and DNA-binding of β-catenin | [14] |
| Fuzheng Huoxue anticancer prescription | Codonopsis pilosula (Franch.) N annf Astragalus membranaceus (Fisch.) Bge, Atractylodes macrocephala Koidz, Poria cocos (Schw.) Wolf, Rehmannia glutinosa (Gaertn.) Lib osch, Adenophoratetraphylla (Thunb.) Fisch, Salvia miltiorrhiza Bge, and Angelica sinensis (Oliv.) Diels | Replenish vital functions (Zhengqi), improve blood stasis and circulation | Mid- or late-stage GC | In vitro (SGC-7901). In vivo (female nude mice) | Correct a hypercoagulatory state, improve immunologic function, extend patient survival times, and inhibit gastric tumor growth | NS | [13] |
| SRRS | Atractylodes macrocephala koidz (Baizhu), Poria cocos Schw. (Fuling), Sargentodoxa cuneata (Oliv.) Rehd. Et Wils. (Daxueteng), Prunella vulgaris L. (Xiakucao) and etc | Nourishing spleen | Advanced GC | In vitro (SGC-7901). In vivo (female BALB/C-nu/nu mice) | Inhibition of gastric cancer cell growth | Decrease the expression of bcl-2 mRNA inducing apoptosis | [109] |
| Composed Chinese medicine of Huachansu | Arenobufagin (11.14%), bufalin (18.67%), bufotalin (7.33%), cinobufagin (16.67%), cinobufotalin (16.74%), gamabufotalin (8.45%), resibufogenin (12.03%), and telocinobufagin (8.97%) | Anticancer | Advanced GC | In vitro (SGC7901, MGC803 and NCM460) | Suppression of proteasome activities and increase of ROS levels | Regulating PI3K/AKT and MAPK signaling pathways | [110] |
| Xiaojianzhong decoction | cassia twigs, paeonia, roasted licorice, ginger, jujube, and maltose sugar | Nourishing spleen and stomach, anticancer | GC | In vitro (AGS, HGC-27, and GES-1) | Suppressing the viability of GC cells, inducing apoptosis, arresting these cells in the G0/G1 phase, and inhibiting cell clone formation | Inhibiting the expression of IL6, PTGS2, MMP9, MMP2, and CCL2 proteins and promoted the expression of the heme oxygenase-1 protein | [111] |
| Yiqi Huayu decoction | Huangqi, Dangshen, Chenpi, Banxia, Baizhu, Baishao, Danggui, Sanleng, Ezhu, Sheshecao, Shijianchuan, Fulin, Muxiang, Sharen, and Gancao | Invigorating qi and invigorating spleen and removing blood stasis | GC after stage II and III operations | In vitro (AGS) | Anti-recurrence and metastasis of GC | Affecting the JAK2-STAT3 pathway and the expression of ACSL4, and induction of ferroptosis | [35] |
| Weifuchun | Radix Ginseng Rubra (red ginseng), Rabdosia amethystoides H. Hara (Xiangchacai), and fried Fructus Aurantii (Zhike) | Strengthen the spleen and replenish qi, promote blood circulation and detoxification, and alleviate flatulence and phlegm | GC | In vitro (AGS, MKN45, and SGC7901) | Inhibiting proliferation, migration, and inducing apoptosis in GC cells | Targeting candidate genes (TNFa, IL6, VEGFA, NFKB, MAPK1, and BAX) | [26] |
| In vitro (NCI-N87, SNU-5, SNU-16, GES-1 cells, and Hs.738. St/Int cells) | Suppressing the malignant cellular phenotypes of GC cells | miR-26a-5p-mediated KPNA2 destabilization and the disruption of the MAPK pathway also enhances the repression of KPNA2 | [32] | ||||
| Daikenchuto | Zanthoxylum fruit (Huajiao), processed dried ginger (Ganjiang), ginseng (Renshen), and malt sugar (Maiyatang) | Stimulates intestinal motility | POI following abdominal surgery | In vivo (male BALB/c mice) | Recovery of the delayed intestinal transit | Inhibited the infiltration of neutrophils and CD68-positive macrophages, and inhibited mRNA expressions of TNF-α and MCP-1 may be partly mediated by activation of α7nAChR | [40] |
| Jianpi Yangzheng decoction | Astragali Radix (Huang Qi) (60 g), Codonopsis Radix (Dang Shen) (30 g), Sparganii Rhizoma (San Leng) (15 g), Curcumae Rhizoma (E Zhu) (15 g), Atractylodis Macrocephalae Rhizoma (Bai Zhu) (10 g), Angelicae Sinensis Radix (Dang Gui) (10 g), Paeoniae Alba Radix (Bai Shao) (10 g), Aucklandiae Radix (Mu Xiang) (10 g), Citri Reticulatae Pericarpium (Chen Pi) (10 g), and Glycyrrhizae Radix (Gan Cao) (5 g) | Anticancer, anti-metastasis | GC after chemotherapy | In vitro (MFC murine GC cell). In vivo (615-strain mice) | Impeding pre-metastatic niche formation and exhibiting anti-tumor metastasis effect | Reshaping the gut microbiota structure, enhancing SCFA production, and inhibiting the formation of the pre-metastatic microenvironment | [30] |
| In vitro (MKN28, AGS, HGC-27, MKN74, MKN45 and MFC). In vivo (male BALB/c-nude mice) | Inhibitory effect on GC growth and metastasis | Elevates the abundance of CLDN18.2 in gastric cancer, suppresses the activity of YAP/TAZ signaling | [31] | ||||
| In vitro (AGS, HGC -27). In vivo (BALB/c nude mice) | Inhibit the invasion and migration of GC | Regulating TAM-exos miR-513 b-5p mediated PTEN/AKT signaling | [29] | ||||
| Modified Jian-pi-yang-zheng decoction | - | Qi-invigorating, spleen-strengthening and stasis-removing | Advanced GC | In vitro (HGC-27 and THP-1 monocytes). In vivo (mice (615-strain) | Suppressed GC growth and metastasis | Inhibit GC cell EMT via PI3Kγ-dependent TAM reprogramming | [28] |
| Modified Gexia-Zhuyu Tang | Peach kernel (9 g), Safflower (9 g), Angelica sinensis (9 g), Chuanxiong (6 g), Red peony (6 g), Peony bark (6 g), YanhuSuo (3 g), Wulingzhi (6 g), Wuyao (6 g), Fructus Aurantii (4.5 g), Xiangfu (4.5 g), Licorice (9 g), Rhizoma atractylodis macrocephalae (12 g), Rhizoma curcumae (9 g), Hedyotis diffusa (15 g), and Scutellaria barbata (15 g) | Anticancer | GC | In vitro (MFC). In vivo (BALB/c male mice) | Inhibited GC tumor progression | Inhibits the growth, proliferation, metastasis, and invasion of GC by regulating the intestinal flora and promotes pyroptosis of GC | [43] |
| Xiaotan Sanjie recipe | Rhizoma Arisaematis, Pinellia Ternata, Atractylodes Macrocephala, Poria Cocos, Fritillaria sichuanensis, White Mustard Seed, Fructus aurantii, Pericarpium Citri Reticulatae, Radish Seed, Galli Gigerii Endothelium Corneum and Medicated Leaven (5:5:4:4:3:3:3:3:2:2:1) | Anti-metastasis | Advanced GC | In vitro (GC-7901, HGC-27, MKN-28, MKN-45, MGC80-3, BGC-823, MKN-7 and KAO-II). In vivo (Female BALB/c-nude mice) | Prevented GC metastasis | Inhibits the GnT-V-mediated E-cadherin glycosylation and promotes the E-cadherin accumulation at cell-cell junctions | [17] |
| In vitro (SGC-7901 cells and HUVEC) | Inhibit angiogenesis in GC | Inhibit angiogenesis in gastric cancer through IL-8-linked regulation of the VEGF pathway | [18] | ||||
| Banxia Xiexin decoction | Pinellia ternata (Thunb.) Makino 12 g, Zingiber officinale Roscoe 9 g, Scutellaria baicalensis Georgi 9 g, Coptis chinensis Franch. 3 g, Panax ginseng C.A.Mey. 9 g, Ziziphus jujuba Mill 12 g, and Glycyrrhiza uralensis Fisch 9 g | Protecting the gastrointestinal mucosa, improving gastrointestinal diseases, regulating human endocrine metabolism | Advanced GC | In vitro (AGS and GES-1) | Inhibits invasion, metastasis, and epithelial mesenchymal transition in GC | Inhibition of lncRNA TUC338 expression | [37] |
| Compound kushen injection | Kushen (Radix Sophorae Flavescentis) and Baituling (Rhizoma Heterosmilacis) | Anticancer, improve body immunity, relieve of cancer pain and bleeding | Advanced GC | In vitro (AGS, HGC-27, MKN-45, MKN-74, GES-1). In vivo (male mice) | Inhibit GC growth and metastasis, improve body's immunity, and protect normal tissues from damage | Regulating VCAM1 induced by the TNF signaling pathway to inhibit epithelial-mesenchymal transition of GC | [34] |
| In vitro (BGC-803/MKN-28) | Inhibited GC cell growth and migration and induced GC cell apoptosis | Regulating the EMT process in GC cells through the PI3K/AKT signalling pathway | [33] | ||||
| Yiwei decoction | Astragalus Membranaceus, Pinellia Ternate, Tetrastigma Hemsleyanum Diels et Gilg, Actinidia chinensis Planch, Ophiopogon Japonicus, Taraxacum mongolicum Hand, Paeonia lactiflora Pall, Coix lacryma-jobi L.var.ma-yuen (Roman.) Stapf, and Rabdosia amethstoides (Benth.) Hara | Anticancer, supplementing qi and strengthening the body | GC recurrence and metastasis | In vitro (HGC-27 , MFC, S180 cells). In vivo (Wistar rats) | Inhibit the proliferation of tumor cells | Inhibition of GC cell proliferation by spleen-derived exosomes inducing apoptosis | [11] |
| Ziyin Huatan recipe | Lilii Bulbus (Baihe.), Pinelliae Rhizoma (Fabanxia) and Hedyotis Diffusa (Baihuasheshecao) | Anti-metastasis | Advanced GC | In vitro (MGC-803 and SGC-790). In vivo (male BALB/c nude mice) | Inhibit migration and invasion of GC | Relate to the upregulation of RUNX3 expression | [19] |
| In vitro (HGC27 and MGC803). In vivo (male BALB/c nude mice) | Inhibit cell proliferation and promote apoptosis in GC | Decrease the expression of Bcl-2 and Cyclin D1, modulate PI3K/AKT signaling pathway by inhibiting PI3K expression | [20] | ||||
| Qi Ling decoction | Astragalus, Smilacisglabrae, Atractylodesmacrocephalae, Scutellariabarbata, Salvia chinensis, Benth, Eupolyphagasteleophaga, Agrimonia, and Forsythia suspense | Anti-metastasis, anti-tumor | Advanced GC | In vitro (BGC-823 and SGC-7901) | Inhibit the invasion, migration, and adhesion of GC cells | Inhibition of MMP-9 expression through the PI3K/AKT signaling pathway | [24] |
| Babao Dan | Natural bezoar, snake gall, antelope horn, pearl, musk, and Panax notoginseng | Anti-metastasis, anti-tumor | Advanced GC | In vitro (AGS and MGC80-3) | Inhibits the migration and invasion of GC cells | Inhibit TGF-β-induced EMT and inactivating TGF-β/ | [36] |
- Citation: Zhao XF, Zhang YJ, Wang SL, Lian FM, Liu Z. Adjuvant role of traditional Chinese medicine in postoperative gastric cancer. World J Clin Oncol 2026; 17(3): 116534
- URL: https://www.wjgnet.com/2218-4333/full/v17/i3/116534.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i3.116534